دورية أكاديمية
أعرض في EDS

Clinicopathological characteristics of cutaneous complications following COVID-19 vaccination: A case series.

التفاصيل البيبلوغرافية
العنوان: Clinicopathological characteristics of cutaneous complications following COVID-19 vaccination: A case series.
المؤلفون: Diab R; Department of Dermatology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Rakhshan A; Department of Pathology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Salarinejad S; Department of Pathology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Pourani MR; Department of Dermatology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Clinical Research Development Unit, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Ansar P; Anesthesia and Critical Care Department, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Abdollahimajd F; Department of Dermatology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Clinical Research Development Unit, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
المصدر: Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Mar; Vol. 23 (3), pp. 725-730. Date of Electronic Publication: 2023 Oct 29.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-2165 (Electronic) Linking ISSN: 14732130 NLM ISO Abbreviation: J Cosmet Dermatol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Oxford, UK : Blackwell Science, c2002-
مواضيع طبية MeSH: Acute Generalized Exanthematous Pustulosis* , COVID-19*/epidemiology , COVID-19*/prevention & control , COVID-19 Vaccines*/adverse effects , Herpes Zoster* , Lichen Planus*, Humans ; Middle Aged ; Vaccination/adverse effects
مستخلص: Introduction: Several vaccine-related cutaneous adverse events occurred following the widespread use of vaccines to prevent coronavirus disease 2019 (COVID-19). This case series reports 25 patients with de novo or accentuated dermatologic conditions after receiving the Sinopharm, Sputnik V, AstraZeneca, or BIV1-CovIran vaccine in Iran.
Methods and Results: Twenty-five eligible patients with a mean age of 46.80 years were investigated. The cutaneous adverse events included pityriasis rosea, zoster, viral exanthema, urticaria, bullous pemphigoid, pemphigus vulgaris, and acute generalized exanthematous pustulosis. The manifestations appeared 14.45 ± 6.98 and 20.79 ± 22.18 days following injection of the first and second doses of COVID-19 vaccines, respectively. All patients experienced new cases of cutaneous disease other than two who developed flare-ups of lichen planus and psoriasis.
Conclusion: Several cutaneous reactions, ranging from allergic events to skin diseases, have been reported following the injection of COVID-19 vaccines. Focal injection-site reactions are the most common cutaneous adverse events; however, de-novo skin diseases and a flare-up of preexisting cutaneous disorders have also been described. Although many cases of COVID-19 vaccine-related cutaneous diseases have been published, our zoster/lichen planus and AGEP cases after vaccination are interesting. A more detailed understanding of cutaneous adverse events following COVID-19 vaccination will facilitate better diagnosis and management.
(© 2023 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.)
References: Russo AG, Decarli A, Valsecchi MG. Strategy to identify priority groups for COVID-19 vaccination: a population based cohort study. Vaccine. 2021;39(18):2517-2525.
Wollina U, Chiriac A, Kocic H, Koch A, Brzezinski P. Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination-a narrative review. Wien Med Wochenschr. 2022;172(3-4):63-69.
Sun Q, Fathy R, McMahon DE, Freeman EE. COVID-19 vaccines and the skin: the landscape of cutaneous vaccine reactions worldwide. Dermatol Clin. 2021;39(4):653-673.
Martora F, Villani A, Battista T, Fabbrocini G, Potestio L. COVID-19 vaccination and inflammatory skin diseases. J Cosmet Dermatol. 2023;22(1):32-33.
Martora F, Battista T, Marasca C, Genco L, Fabbrocini G, Potestio L. Cutaneous reactions following COVID-19 vaccination: a review of the current literature. Clin Cosmet Investig Dermatol. 2022;15:2369-2382.
Gambichler T, Boms S, Susok L, et al. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol. 2022;36(2):172-180.
Wei TS. Cutaneous reactions to COVID-19 vaccines: a review. JAAD Int. 2022;7:178-186.
Temiz SA, Abdelmaksoud A, Wollina U, et al. Cutaneous and allergic reactions due to COVID-19 vaccinations: a review. J Cosmet Dermatol. 2022;21(1):4-12.
Pourani MR, Shahidi Dadras M, Salari M, Diab R, Namazi N, Abdollahimajd F. Cutaneous adverse events related to COVID-19 vaccines: a cross-sectional questionnaire-based study of 867 patients. Dermatol Ther. 2022;35(2):e15223.
Niebel D, Novak N, Wilhelmi J, et al. Cutaneous adverse reactions to COVID-19 vaccines: insights from an immuno-dermatological perspective. Vaccine. 2021;9(9):944.
Cebeci Kahraman F, Savaş Erdoğan S, Aktaş ND, et al. Cutaneous reactions after COVID-19 vaccination in Turkey: a multicenter study. J Cosmet Dermatol. 2022;21(9):3692-3703.
Qaderi K, Golezar MH, Mardani A, et al. Cutaneous adverse reactions of COVID-19 vaccines: a systematic review. Dermatol Ther. 2022;35(5):e15391.
Wang C-S, Chen H-H, Liu S-H. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: a case report and literature review. J Formos Med Assoc. 2022;121(5):1003-1007.
Dursun R, Temiz SA. The clinics of HHV-6 infection in COVID-19 pandemic: pityriasis rosea and Kawasaki disease. Dermatol Ther. 2020;33(4):e13730.
Katsikas Triantafyllidis K, Giannos P, Mian IT, Kyrtsonis G, Kechagias KS. Varicella zoster virus reactivation following COVID-19 vaccination: a systematic review of case reports. Vaccine. 2021;9(9):1013.
Iwanaga J, Fukuoka H, Fukuoka N, Yutori H, Ibaragi S, Tubbs RS. A narrative review and clinical anatomy of herpes zoster infection following COVID-19 vaccination. Clin Anat. 2022;35(1):45-51.
Maronese CA, Caproni M, Moltrasio C, et al. Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicentre study. Front Med. 2022;9:841506.
Calabria E, Canfora F, Mascolo M, Varricchio S, Mignogna MD, Adamo D. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: a case report of pemphigus vulgaris and a literature review. Pathol Res Pract. 2022;232:153834.
Karampinis E, Gravani A, Gidarokosta P, Bogdanos DP, Roussaki-Schulze A-V, Zafiriou E. Pustular eruption following COVID-19 vaccination: a narrative case-based review. Vaccine. 2023;11(8):1298.
Potestio L, Fabbrocini G, D'Agostino M, Piscitelli I, Martora F. Cutaneous reactions following COVID-19 vaccination: the evidence says “less fear”. J Cosmet Dermatol. 2023;22(1):28-29.
فهرسة مساهمة: Keywords: COVID-19; adverse events; complication; pathology; vaccine
المشرفين على المادة: 0 (COVID-19 Vaccines)
تواريخ الأحداث: Date Created: 20231030 Date Completed: 20240226 Latest Revision: 20240229
رمز التحديث: 20240229
DOI: 10.1111/jocd.16042
PMID: 37899662
قاعدة البيانات: MEDLINE
الوصف
تدمد:1473-2165
DOI:10.1111/jocd.16042